Bicara Therapeutics Inc. (BCAX) stock
BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.60−0.15 (-1.54%)
Close on Nov 17, 2026Market cap $635.26MP/E –Yield –
Bicara Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bicara Therapeutics's enterprise value was $197.00M on Nov 11, 2026, against $723.44M a year earlier. Over the last 2 years it ranged from -$215.28M to $1.41B, with a median of $427.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $197.00M | -68.7% |
| 2025 | Dec 31, 2025 | $628.96M | +47.3% |
| 2024 | Dec 31, 2024 | $427.06M | – |
See a number that looks wrong?